Global NICU Genetic Testing Market OverviewThe global NICU Genetic Testing Market is projected to grow at a CAGR of ...

A major genetic analysis of over 3,200 Japanese individuals reveals a more complex ancestry than previously thought, ...

U.S. Genomic Medicine Market was valued at USD 9.93 billion in 2025 and is expected to reach USD 32.9 billion by 2035 owing to the increasing use of personalized medicineAustin, May 14, 2026 (GLOBE ...

Scientists analyzing the genomes of thousands of people across Japan discovered evidence for a previously overlooked third ...

For sixty years, scientists told the same story about Japanese ancestry. The population descended from two ancient groups: ...

According to MarketsandMarkets™, the Molecular Infectious Disease Testing Market is projected to grow from about USD 11.30 ...

The global DNA Polymerase Market is projected to expand from USD 397.7 million in 2025 to USD 725.8 million by 2035, growing ...

Key opportunities lie in reagents & consumables due to their high usage, drug discovery's large market share, and significant ...

Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, ...

Illumina () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smart ...

Illumina Inc (ILMN) reports robust Q1 performance with increased revenue and EPS, while raising 2026 guidance amid strong clinical market demand.

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 4.8% year on year to $1.09 billion. The company’s full-year revenue ...